Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Severe Motility Disorder
NCT04373252Phase 1Withdrawn
- Sponsor
- University of Colorado Denver
- Start
- Jul 2021
- Primary completion
- Jul 2021
- Modality
- Live Biotherapeutic Products
01
Overview
Phase 1, open-label, single-arm trial of fecal microbiome transplant in fecal incontinence (FI) and gastrointestinal motility disorder, sponsored by University of Colorado Denver. Primary endpoint: Patients become responsive to daily enema treatments again at 1 year. Planned start Jul 2021; status: withdrawn.
02
Drugs
fecal microbiome transplant
03
Conditions
fecal incontinence (FI)gastrointestinal motility disorder
Beyond the preview
Go deeper on NCT04373252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04373252.